Daniel Kapp

Professor of Radiation Oncology, Emeritus

Academic Appointments

Emeritus Faculty, Acad Council, Radiation Oncology - Radiation Therapy
Member, Stanford Cancer Institute

Current Research and Scholarly Interests

Gynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.

Clinical Trials

Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer Not Recruiting
More
This randomized phase III trial is studying cisplatin, radiation therapy, and tirapazamine to see how well they work compared to cisplatin and radiation therapy in treating patients with cervical cancer. Drugs used in chemotherapy, such as cisplatin and tirapazamine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Cisplatin and tirapazamine may make tumor cells more sensitive to radiation therapy. It is not yet known whether giving cisplatin together with radiation therapy is more effective with or without tirapazamine in treating cervical cancer.

Stanford is currently not accepting patients for this trial. For more information, please contact Maureen Sutton, 6507259167.
Lead Sponsor
Stanford Investigators
View full details

2023-24 Courses

Independent Studies
- Directed Reading in Radiation Oncology
  RADO 299 (Aut)
- Early Clinical Experience in Radiation Oncology
  RADO 280 (Aut)
- Graduate Research
  RADO 399 (Aut)
- Medical Scholars Research
  RADO 370 (Aut)
- Readings in Radiation Biology
  RADO 101 (Aut, Sum)
- Undergraduate Research
  RADO 199 (Aut)

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources

Daniel Kapp

Professor of Radiation Oncology, Emeritus

Stanford Investigators

2023-24 Courses

Daniel Kapp

Professor of Radiation Oncology, Emeritus

Lead Sponsor

Stanford Investigators